Search
Epigallocatechin gallate
go.drugbank.com/drugs/DB12116InvestigationalEpigallocatechin gallate has been investigated for the treatment of Hypertension and Diabetic Nephropathy.
Categories: Compounds used in a research, industrial, or household settingDifluprednate
go.drugbank.com/drugs/DB06781ApprovedInvestigationalDifluprednate is a topical corticosteroid indicated for the treatment of infammation and pain associated with ocular surgery. It is a butyrate ester of 6(α), 9(α)-difluoro prednisolone acetate. … Difluprednate is abbreviated DFBA, or difluoroprednisolone butyrate acetate. It is indicated for treatment of endogenous anterior uveiti.
Cobaltous sulfate
go.drugbank.com/drugs/DB15760InvestigationalMixtures: VINATAL DHA CAPSULA DE GELATINA BLANDAArundic acid
go.drugbank.com/drugs/DB05343InvestigationalArundic acid has been investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS).
ETC-588
go.drugbank.com/drugs/DB05456ExperimentalEsperion is currently developing ETC-588 as a treatment for patients with acute coronary syndromes. … It is believed that the removal of cholesterol by ETC-588 through this pathway may result in the reversal of atherosclerosis.
Sarracenia Purpurea
go.drugbank.com/drugs/DB13965ApprovedWithdrawnIt is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities [A32509, A32510]. … _Sarracenia purpurea_, commonly known as the purple pitcher plant, northern pitcher plant, turtle socks, or side-saddle flower, is a perennial carnivorous plant in the family _Sarraceniaceae_.
Synonyms: Sarracenia purpurea l.N4-Hydroxycytidine
go.drugbank.com/drugs/DB15660ExperimentalN4-Hydroxyctidine, or EIDD-1931, is a ribonucleoside analog which induces mutations in RNA virions. … [A193008,A193011] N4-hydroxycytidine was first described in the literature in 1980 as a potent mutagen of bacteria and phage.
Synonyms: beta-D-N-4-Hydroxycytidine, β-D-N4-hydroxycytidineSGS518
go.drugbank.com/drugs/DB05042ExperimentalSGS518, a novel antagonist for the 5HT6 subtype of the serotonin receptor, is being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS).